Privacy, Pediatrics, and Policy

March 1, 2001
Jill Wechsler, Pharm Exec's Washington Correspondent

Jill Wechsler is Pharm Exec's Washington Corespondent

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-03-01-2001, Volume 0, Issue 0

FDA proposals for expanding the pediatric study program include tax incentives and }transferable exclusivity.}

Related Content:

News